Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain
Crossref DOI link: https://doi.org/10.1007/s40261-015-0345-z
Published Online: 2015-11-07
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rodríguez González-Moro, Jose Miguel
Menéndez, Rosario
Campins, Magda
Lwoff, Nadia
Oyagüez, Itziar
Echave, María
Rejas, Javier
Antoñanzas, Fernando
Funding for this research was provided by:
Pfizer S.L.U Spain
License valid from 2015-11-07